Fentanyl Transdermal Patch and Tocilizumab: Interaction Details
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fentanyl Transdermal Patch and Tocilizumab interaction:
Fentanyl Transdermal Patch
- Duragesic
- Abstral
- Subsys
- Ionsys
- Actiq
- Fentora
Tocilizumab
- Actemra
- Avtozma
- Tofidence
- Tyenne
We don't have a drug information page for Tocilizumab yet. Have a question about Tocilizumab? Ask a pharmacist, free →
What Happens When You Take Fentanyl Transdermal Patch With Tocilizumab
What can happen when they are taken together (rated Major)
Reduced with NTI exposure and reduced of CYP3A4 substrate with NTI
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
When tocilizumab is given together with a CYP3A4 substrate that has a (NTI), exposure to that substrate may fall. Clinical studies of CYP3A4 substrates (omeprazole, simvastatin and dextromethorphan) found lower exposure one week after a single tocilizumab dose.
For patients treated with a CYP3A4 NTI substrate, therapeutic effect or drug concentrations should be monitored, and the individual dose of the substrate adjusted as needed, both when tocilizumab is started and when it is stopped. Tocilizumab's influence on enzyme activity can last for several weeks after therapy ends. Caution is also advised when tocilizumab is coadministered with CYP3A4 substrates such as oral contraceptives, lovastatin and atorvastatin, among others, for which a loss of effectiveness is undesirable.123
The Fentanyl Transdermal Patch and Tocilizumab Interaction, Explained
Tocilizumab (Actemra and similar) is used for conditions like rheumatoid arthritis. It calms inflammation, and as a side effect it can switch your liver's enzyme back up to its normal speed. Your body uses that enzyme to break down fentanyl, the pain medicine in the Duragesic patch.
If the enzyme works faster, less fentanyl may stay in your body, so the patch may not control your pain as well as it did before. This can show up within a week after a dose, and it can last for several weeks after tocilizumab is stopped. Keep wearing your patch as prescribed and tell your pharmacist or doctor if your pain changes. Your care team can monitor you and individualize your dose as needed.
Mechanism: Tocilizumab (IL-6 receptor ) reverses IL-6 mediated suppression of expression, effectively increasing activity. Fentanyl is a CYP3A4 (not a ), so exposure may fall.
- Direction: decreased fentanyl exposure (/), with possible loss of analgesia and withdrawal symptoms.
- Evidence: probable. Labeled studies showed reduced exposure of omeprazole, simvastatin and dextromethorphan about one week after a single dose. Fentanyl-specific data are not described.
- Onset/duration: unspecified; effect may persist several weeks after discontinuation.
- Management: monitor analgesic response (and drug concentrations where applicable) at initiation and discontinuation of tocilizumab. Individualize the fentanyl dose as needed. Be alert for overdose risk if tocilizumab is stopped and CYP3A4 activity falls back.
See the 3 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fentanyl Transdermal Patch and Tocilizumab Interact
The likely mechanism
of -mediated by tocilizumab
How to Manage the Fentanyl Transdermal Patch and Tocilizumab Interaction
Your care team can manage this by watching how well your pain is controlled and tailoring your fentanyl dose.
- Keep using both medicines as prescribed. Do not change or stop either one on your own.
- Your team may monitor you more closely when tocilizumab is started or stopped, and the fentanyl dose may need to be adjusted and individualized.
- The effect on liver enzymes can last for several weeks after tocilizumab ends, so keep your team informed during that time.
- Tell your pharmacist or prescriber if your pain returns or worsens, or if you notice withdrawal-like symptoms. Also report unusual sleepiness or slowed breathing, especially after tocilizumab is stopped.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fentanyl Transdermal Patch or Tocilizumab need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
2 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: AVTOZMA intravenous, subcutanous injection, tocilizumab-anoh intravenous, subcutanous injection
-
Report 2 · Study title
Prescribing information: TYENNE intravenous, subcutaneous injection, tocilizumab-aazg intravenous, subcutaneous injection
In drug interaction studies, 13 RA patients received 30 mg dextromethorphan (a and ), and their exposure to dextromethorphan was comparable to that of healthy subjects. Exposure to its , dextrorphan (a CYP3A4 substrate), was only a fraction of that seen in healthy subjects. One week after a single tocilizumab infusion (8 mg per kg), dextromethorphan exposure was reduced by approximately 5%, whereas dextrorphan levels showed a larger reduction (29%) following the infusion.2
Fentanyl Transdermal Patch and Tocilizumab: Common Questions
How serious is the Fentanyl Transdermal Patch and Tocilizumab interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fentanyl Transdermal Patch and Tocilizumab interaction managed?
Your care team can manage this by watching how well your pain is controlled and tailoring your fentanyl dose. Keep using both medicines as prescribed. Do not change or stop either one on your own. Your team may monitor you more closely when tocilizumab is started or stopped, and the fentanyl dose may need to be adjusted and individualized. The effect on liver enzymes can last for several weeks aft… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Fentanyl Transdermal Patch and Tocilizumab Interaction
Ask in your own words about taking Fentanyl Transdermal Patch and Tocilizumab together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (3)
- Product Information: AVTOZMA(R) intravenous, subcutanous injection, tocilizumab-anoh intravenous, subcutanous injection. CELLTRION USA, Inc. Jersey City, NJ, 2025. DailyMed
- Product Information: TYENNE(R) intravenous, subcutaneous injection, tocilizumab-aazg intravenous, subcutaneous injection. Fresenius Kabi USA, LLC (Per FDA), Lake Zurich, IL, 2024. DailyMed
- Product Information: TOFIDENCE(TM) intravenous injection, tocilizumab-bavi intravenous injection. Biogen MA Inc (per FDA), Cambridge, MA, 2023. DailyMed
Other Serious Interactions of Fentanyl Transdermal Patch and Tocilizumab
Also serious with Fentanyl Transdermal Patch
- IsocarboxazidContraindicated
- LevoketoconazoleContraindicated
- NaltrexoneContraindicated
- PhenelzineContraindicated
Also serious with Tocilizumab
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Tocilizumab
- WineMajor
- BeerMajor
- Siberian CockleburMajor
- Vitamin AModerate
- SeleniumModerate
- TurmericModerate
- Green TeaModerate
- AshwagandhaModerate
- + 81 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.